Literature DB >> 24551627

Method Validation for Analysis of Simvastatin in Human Plasma Using Liquid Chromatography Tandem Mass Spectrometry (LC-MS-MS).

Khaled M Alakhali1.   

Abstract

INTRODUCTION: The Liquid Chromatography Tandem Mass Spectrometry (LC-MS-MS) for determination simvastatin in human plasma has been developed after extraction by by ethyl acetate and hexane (90/10%, v/v) using lovastatin as internal standard.
MATERIAL AND METHODS: The mobile phase consisting of mixture of acetonitrile and water (75/25%, v/v) 500μL/min by separated the solutes on a C18 column. DISCUSSION: The lower limit of quantitation of 0.25 ng/mL was achieved when the calibration curve was linear from 0.25-50 ng/mL. The entire run time for analysis was only 6 min. The quantitation in the selective reaction monitoring (SRM) in positive ion mode, the daughter ions m/z 325 for simvastatin and m/z 285 for lovastatin were used. The Parent ions in positive ion mode were m/z 441.3 for simvastatin and m/z 405.1 for lovastatin. The intra-day coefficients of variation were less than 14% while the inter-day coefficients of variation were less than 10%.
CONCLUSION: The LC-MS-MS detection is sensitive due to its capability to eliminate interferences from endogenous components.

Entities:  

Keywords:  Human plasma; Liquid Chromatography Tandem Mass Spectrometry; Simvastatin

Year:  2013        PMID: 24551627      PMCID: PMC3919302          DOI: 10.7860/JCDR/2013/6261.3748

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Direct-injection LC-MS-MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasma.

Authors:  M Jemal; Z Ouyang; M L Powell
Journal:  J Pharm Biomed Anal       Date:  2000-08-15       Impact factor: 3.935

Review 2.  Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.

Authors:  Md Khalid Pasha; Syed Muzeeb; Shaik Jafar Sadik Basha; Dhanya Shashikumar; Ramesh Mullangi; Nuggehally R Srinivas
Journal:  Biomed Chromatogr       Date:  2006-03       Impact factor: 1.902

3.  Validated HPLC-MS/MS method for simultaneous determination of simvastatin and simvastatin hydroxy acid in human plasma.

Authors:  B Barrett; J Huclová; V Borek-Dohalský; B Nemec; I Jelínek
Journal:  J Pharm Biomed Anal       Date:  2005-12-27       Impact factor: 3.935

4.  Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.

Authors:  M J Morris; J D Gilbert; J Y Hsieh; B K Matuszewski; H G Ramjit; W F Bayne
Journal:  Biol Mass Spectrom       Date:  1993-01

5.  Determination of simvastatin and its active metabolite in human plasma by column-switching high-performance liquid chromatography with fluorescence detection after derivatization with 1-bromoacetylpyrene.

Authors:  H Ochiai; N Uchiyama; K Imagaki; S Hata; T Kamei
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-06-20

6.  Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast and Zocor) in healthy human volunteers.

Authors:  Naji M Najib; Nasir Idkaidek; Ayman Adel; Isra' Admour; Rafel E B Astigarraga; Gliberto De Nucci; S Mahmood Alam; Ruwayda Dham
Journal:  Biopharm Drug Dispos       Date:  2003-07       Impact factor: 1.627

Review 7.  Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.

Authors:  G L Plosker; D McTavish
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  Determination of Simvastatin in human plasma by liquid chromatography-mass spectrometry.

Authors:  Haitao Yang; Yan Feng; Yiwen Luan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-03-05       Impact factor: 3.205

Review 9.  Clinical pharmacokinetics and practical applications of simvastatin.

Authors:  V F Mauro
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

10.  Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by high-performance liquid chromatography with UV detection.

Authors:  G Carlucci; P Mazzeo; L Biordi; M Bologna
Journal:  J Pharm Biomed Anal       Date:  1992-09       Impact factor: 3.935

View more
  2 in total

1.  Clinical Pharmacokinetic Drug Interaction Potential of MenoAct851 in Adult, Female Healthy Volunteers.

Authors:  Vijayakumar Thangavel Mahalingam; Ilango Kaliappan; Satish Kumar Rajappan Chandra; Melvin George; Mohan Kumar Ramasamy; Sarvesh Sabarathinam; Dubey Govind Prasad
Journal:  Curr Ther Res Clin Exp       Date:  2020-12-08

2.  Detection and characterization of simvastatin and its metabolites in rat tissues and biological fluids using MALDI high resolution mass spectrometry approach.

Authors:  Wencui Yin; Reem I Al-Wabli; Mohamed W Attwa; A F M Motiur Rahman; Adnan A Kadi
Journal:  Sci Rep       Date:  2022-03-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.